Switch to:
Johnson & Johnson  (NYSE:JNJ) Accounts Receivable: \$13,283 Mil (As of Jun. 2017)

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Johnson & Johnson's accounts receivables for the quarter that ended in Jun. 2017 was \$13,283 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Johnson & Johnson's Days Sales Outstanding for the quarter that ended in Jun. 2017 was 64.34.

In Ben Graham's calculation of liquidation value, accounts receivable are only considered to be worth 75% of book value. Johnson & Johnson's Net-Net Working Capital for the quarter that ended in Jun. 2017 was \$-53,220 Mil.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Johnson & Johnson Annual Data

 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Accounts Receivable 11,309.00 11,713.00 10,985.00 10,734.00 11,699.00

Johnson & Johnson Quarterly Data

 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Accounts Receivable 11,798.00 11,699.00 12,300.00 13,283.00 0.00

Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Johnson & Johnson's Days Sales Outstanding for the quarter that ended in Jun. 2017 is calculated as:

 Days Sales Outstanding = Accounts Receivable / Revenue * Days in Period = 13283 / 18839 * 91 = 64.34

2. In Ben Graham's calculation of liquidation value, Johnson & Johnson's accounts receivable are only considered to be worth 75% of book value:

Johnson & Johnson's liquidation value for the quarter that ended in Jun. 2017 is calculated as:

 Liquidation value = Cash And Cash Equivalents - Total Liabilities + (0.75 * Accounts Receivable) + (0.5 * Total Inventories) = 12853 - 80885 + 0.75 * 13283 + 0.5 * 9699 = -53,220

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Related Terms

From GuruFocus

###### Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2017

By PRNewswire about JNJ 2017-10-19 06:00:34

From the Internet

###### Healthcare ETFs in Focus on Johnson & Johnson Q3 Earnings

- Zacks 2017-10-19 11:13:00

###### Can ImmunoGen's Key Pipeline Cancer Candidate Drive Growth?

- Zacks 2017-10-19 08:51:00

###### Varian Medical (VAR) Initiates Halcyon Treatment in Europe

- Zacks 2017-10-19 08:38:00

###### Market Waiting Tax Reform Cramers Mad Money 10 18 17

- Seekingalpha 2017-10-19 07:40:47

###### How Jim Cramer Skillfully Navigated the 1987 Black Monday Crash -- Video

- theStreet 2017-10-19 07:40:00

###### J And J Unattractive

- Seekingalpha 2017-10-19 00:18:42

###### 3 Stocks to Buy and Hold for 100 Years

- Fool 2017-10-18 21:00:00

###### Rally's Not Waiting on Tax Reform: Cramer's 'Mad Money' Recap

- theStreet 2017-10-18 18:55:00

###### What to Expect from Big Pharmas After J&J's Solid Q3 Results?

- Zacks 2017-10-18 15:21:00

###### Dow ETFs Soar as the Index Hits 23,000

- Zacks 2017-10-18 15:19:00

###### Johnson And Johnson Fully Priced Operating Momentum Accelerates

- Seekingalpha 2017-10-18 14:22:10

###### Impact Fasbs Pension Cost Accounting Rule Change

- Seekingalpha 2017-10-18 12:00:16

###### 16 61 Safer Dividend Healthcare Dogs October

- Seekingalpha 2017-10-18 11:23:24

###### Johnson And Johnson Time Highs Time Sell Buy

- Seekingalpha 2017-10-18 10:25:06

###### Stock Market News For Oct 18, 2017

- Zacks 2017-10-18 09:44:00

###### Dow Opens Above 23,000 as Stocks Continue to Push Higher

- theStreet 2017-10-18 09:33:00

###### Johnson And Johnson One Time Bumps

- Seekingalpha 2017-10-18 08:48:32

###### Johnson And Johnson Q3 Beat Low Quality

- Seekingalpha 2017-10-18 08:22:59

###### Markets May Cheaper Think Cramers Mad Money 10 17 17

- Seekingalpha 2017-10-18 07:39:22

###### Dow Set to March Past 23,000 After IBM's Quarterly Beat

- theStreet 2017-10-18 07:37:00

###### Johnson And Johnson Unsinkable

- Seekingalpha 2017-10-18 07:25:07

###### Wall Street Breakfast Markets Eye Chinas Party Congress

- Seekingalpha 2017-10-18 07:03:55

###### What's Powering Johnson & Johnson's Impressive Quarterly Earnings?

- Fool 2017-10-18 06:31:00

###### Johnson And Johnson Amazing Company Something Wrong

- Seekingalpha 2017-10-17 23:17:11

###### 3 Things You Won't Learn by Focusing on Johnson & Johnson's Headline Figures in Its Q3 Report

- Fool 2017-10-17 21:12:00

###### Are Stocks Cheaper Than We Think?: Cramer's 'Mad Money' Recap

- theStreet 2017-10-17 19:01:00

###### Insurers Boosted by Bipartisan Health Plan; Siris Lands Synchronoss Unit - ICYMI

- theStreet 2017-10-17 18:33:00

###### What Happened in the Stock Market Today

- Fool 2017-10-17 17:12:00

###### UnitedHealth and Insurance Agreement Lead Dow, S&P 500 to Records

- theStreet 2017-10-17 16:25:00

###### UnitedHealth and a Bipartisan Healthcare Deal Sends Dow, S&P 500 to Records

- theStreet 2017-10-17 16:13:00

###### Johnson & Johnson Q3 2017 Earnings Conference Call Transcript (JNJ)

- Fool 2017-10-17 15:53:00

###### Bipartisan Deal on Obamacare Subsidies Boosts Insurance Stocks

- theStreet 2017-10-17 15:08:00

###### J&J wins reversal of \$72 million verdict over talc cancer risks

- cnbc 2017-10-17 14:33:07

###### Johnson & Johnson Jumps on Pharma Strength

- Fool 2017-10-17 13:18:00

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)